Table 4. Multivariate analysis of recurrence-free survival and overall survival.
Variables | Overall survival | Recurrence-free survival | |||
---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | ||
Age ≥65 vs. <65 years | 3.78 (1.60–10.44) | 0.0026 | 2.85 (1.44–6.07) | 0.0027 | |
Male vs. female | 6.17 (2.55–17.03) | <0.0001 | 2.91 (1.49–6.02) | 0.0018 | |
Lepidic predominant vs. non-lepidic | 0.45 (0.17–1.12) | 0.084 | 0.25 (0.11–0.54) | 0.0004 | |
pN1, N2 vs. pN0 | 6.19 (2.35–15.92) | <0.0001 | 7.30 (3.42–15.31) | <0.0001 | |
CD8 high vs. low | 0.19 (0.08–0.46) | 0.0001 | 0.28 (0.13–0.56) | 0.0002 | |
CCR4 high vs. low | 2.24 (1.01–5.34) | 0.049 | 2.20 (1.16–4.39) | 0.017 |
HR, hazard ratio; CI, confidence interval.